Breaking News, Financial News

Financial Report: Johnson & Johnson 1Q

Worldwide pharmaceutical sales were $5.8 billion in the quarter (-10%) with an operational decline of 5% and a negative impact from currency of 5%. Domestic sales were down 10%.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Johnson & Johnson 1Q 1Q Revenues: $15.0 billion (-7%) 1Q Earnings: $3.5 billion (-3%) Comments: Worldwide pharmaceutical sales were $5.8 billion in the quarter (-10%) with an operational decline of 5% and a negative impact from currency of 5%. Domestic sales were down 10%. International sales were down 11%, which reflected an operational increase of 3% and a negative currency impact of 14%. Concerta sales were up 19% to $344 million; Remicade sales were $1.0 billion (+3%); Invega sa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters